Flagship Pioneering CEO Noubar Afeyan at Endpoints JPM24 (Brian Benton Photography)
July 10, 2024 11:30 AM EDT
Financing
Startups

Flag­ship's Noubar Afeyan on un­cer­tain­ty, AI and biotech’s fu­ture

Kyle LaHucik

Biotech Correspondent

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

US warns drug­mak­ers against mis­rep­re­sent­ing cost of im­port­ed prod­ucts

Trump asks 'very tough hom­bre' Dr. Oz to lead MFN talks

End­points 100 biotech sur­vey: Wel­come to the sum­mer of biotech’s dis­con­tent

About 5% of CBER and CDER left af­ter FDA staff cuts, analy­sis finds

Merus’ Phase 2 over­all sur­vival da­ta reach ‘home run’ sce­nario — an­a­lyst

sponsored

Does your sup­ply chain hold up un­der pres­sure for high-risk tem­per­a­ture-crit­i­cal ship­ments?

A service from the Financial Times